Inflammatory Bowel Diseases 1990: Proceedings of the Third International Symposium on Inflammatory Bowel Diseases, Jerusalem, September 10–13, 1989D. Rachmilewitz, George O. Zimmerman Springer Science & Business Media, 28 feb 1990 - 280 páginas The Third International Symposium on Inflammatory Bowel Diseases was held in Jerusalem during September 10-13, 1989. Four hundred physicians and scientists from 25 countries attended the meeting. The symposium was organized into five panels devoted to state of the art reviews of the latest findings and approaches on the etiology, pathogenesis, metabolic implications, clinical assessment of disease activity and the medical management of IBD. Several issues were discussed in debate form. The last panel was dedicated to discussion of three patients with computer assisted active participation of all the attendants. In addition, 03 abstracts were presented as posters, all of which were published in the Book of Abstracts. The organizing committee gratefully acknowledges the contributors who presented their work in clear and concise manner and the participants, whose active part in the discussions contributed to the success of the meeting. The Jerusalem International symposium on Inflammatory Bowel Diseases has become a tradition that will continue with the Fourth Symposium to be convened in September 1993. Joseph Zimmerman, M.D. Daniel Rachmi1ewitz, M.D. LIST OF FIRST AUTHORS Theodore M. Bayless, Michael J. Langman, Johns Hopkins University Department of Medicine, School of Medicine, Queen Elizabeth Hospital, Baltimore, Maryland. Birmingham, England. Michael D. Blackstone, J.E. Lennard-Jones, University of Chicago, St. Mark's Hospital, Chicago, Illinois. City Road, London, England. Charles O. Elson, Division of Gastroenterology, James Lee Madara, The University of Alabama Department of Pathology, at Birmingham, Brigham and Women's Hospital, Birmingham, Alabama. Boston, Massachusetts. |
Índice
III | 13 |
IV | 13 |
V | 19 |
VI | 27 |
VII | 35 |
VIII | 45 |
IX | 49 |
X | 59 |
XVIII | 121 |
XIX | 129 |
XX | 141 |
XXI | 159 |
XXII | 167 |
XXIII | 179 |
XXIV | 213 |
XXV | 219 |
XI | 65 |
XII | 71 |
XIII | 79 |
XIV | 89 |
XV | 97 |
XVI | 107 |
XVII | 115 |
XXVI | 235 |
XXVII | 243 |
XXVIII | 255 |
XXIX | 267 |
275 | |
Otras ediciones - Ver todo
Inflammatory Bowel Diseases 1990: Proceedings of the Third International ... D. Rachmilewitz,George O. Zimmerman Vista previa restringida - 2012 |
Inflammatory Bowel Diseases 1990: Proceedings of the Third International ... D. Rachmilewitz,George O. Zimmerman No hay ninguna vista previa disponible - 2014 |
Inflammatory Bowel Diseases 1990: Proceedings of the Third International ... D. Rachmilewitz,George O. Zimmerman No hay ninguna vista previa disponible - 2014 |
Términos y frases comunes
1990 Kluwer Academic 5-aminosalicylic acid abnormalities absorption active ulcerative colitis acute agents antibodies antigens Asacol azathioprine biopsies bone Bowel Diseases 1990 bowel rest calcium cancer carcinoma cells chronic Clin clinical colectomy colonic mucin colonic mucosa colonoscopy controlled trial corticosteroids Crohn's disease cyclosporin demonstrated Dipentum disease activity distal dose drug dysplasia efficacy elemental diet endoscopic enemas epithelial factor fistulae g/day Gastroenterol Gastroenterology gastrointestinal genetic growth histologic ileum immune immunosuppressive improvement increased infection inflammation inflammatory bowel disease intestinal Lancet Lennard-Jones lesions maintenance Medical mesalazine metabolism methotrexate mucosa mycobacteria normal olsalazine oral patients with Crohn's patients with inflammatory patients with ulcerative Pentasa placebo platelet-activating factor prednisone Rachmilewitz recurrence relapse remission reported resection response risk role SASP Scand Seidman small bowel steroids sulfasalazine surgery surveillance therapeutic therapy tissue total parenteral nutrition toxicity treated treatment of ulcerative ulcerative colitis vitamin vitamin D Zimmerman eds